Lista de obras -

'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin

artículo científico publicado en 2019

Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants ⬇️

artículo científico publicado el 1 de febrero de 2013

Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement

artículo científico publicado el 1 de enero de 2012

Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation

artículo científico publicado en 2012

Bridging therapy: a challenging area in the management of patients with atrial fibrillation

artículo científico publicado en 2013

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

scientific article published on 15 April 2020

Cardiac arrhythmias in patients with COVID-19

artículo científico publicado en 2020

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry

artículo científico publicado en 2020

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

artículo científico publicado en 2017

Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population

artículo científico publicado en 2016

Embolic stroke of undetermined source: The need for an integrated and holistic approach to care

scientific article published on 11 December 2020

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?

artículo científico publicado en 2018

Heart failure in East Asia

artículo científico publicado en 2013

How early is early enough to prevent stroke in atrial fibrillation?

artículo científico publicado en 2012

Identification of microRNA biomarkers in serum of patients at different stages of atrial fibrillation

artículo científico publicado en 2020

Inflammation in atrial fibrillation

artículo científico publicado en 2012

Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism

artículo científico publicado en 2015

Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial"

scientific article published on 10 June 2019

Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation"

artículo científico publicado en 2020

Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more

scientific article published on 07 April 2020

Mobile Health (mHealth) technology for improved screening, patient involvement and optimizing integrated care in atrial fibrillation: The mAFA (mAF-App) II randomized trial

article

Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial

artículo científico publicado en 2017

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

scientific article published on 01 April 2020

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial

artículo científico publicado en 2020

Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation

scientific article published on 02 September 2019

Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation

artículo científico publicado en 2020

Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort

scientific article published on 13 October 2020

Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke

artículo científico publicado en 2015

Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study

artículo científico publicado en 2018

Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients

artículo científico publicado en 2012

Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with

artículo científico publicado en 2012

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

artículo científico publicado en 2020

Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project

artículo científico publicado en 2014

Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study

scientific article published on 15 May 2020

Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation

artículo científico publicado en 2015

Regular bleeding risk assessment associated with reduction in bleeding outcomes: The mAFA II randomised trial

scientific article published on 11 April 2020

Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation ⬇️

artículo científico publicado el 30 de enero de 2013

Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening

artículo científico publicado en 2020

Reply: To PMID 22858389.

artículo científico publicado en 2013

Risk factors for new-onset atrial fibrillation: A focus on Asian populations

artículo científico publicado en 2018

Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.

artículo científico publicado en 2013

Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations

artículo científico publicado en 2020

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact? ⬇️

artículo científico publicado el 23 de octubre de 2012

Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study

artículo científico publicado en 2023

The Challenge of Antiplatelet Therapy in Patients with Atrial Fibrillation and Heart Failure ⬇️

artículo científico publicado el 4 de diciembre de 2012

The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management

artículo científico publicado en 2019

The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection

artículo científico publicado en 2020

The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia ⬇️

artículo científico publicado el 1 de julio de 2012

Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation

artículo científico publicado en 2015

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation

artículo científico publicado en 2012

Lista de obras de

'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin

Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants ⬇️

Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement

Bridging Therapy: A Challenging Area in the Management of Patients with Atrial Fibrillation

Bridging therapy: a challenging area in the management of patients with atrial fibrillation

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Cardiac arrhythmias in patients with COVID-19

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

Determinants and Time Trends for Ischaemic and Haemorrhagic Stroke in a Large Chinese Population

Embolic stroke of undetermined source: The need for an integrated and holistic approach to care

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?

Heart failure in East Asia

How early is early enough to prevent stroke in atrial fibrillation?

Identification of microRNA biomarkers in serum of patients at different stages of atrial fibrillation

Inflammation in atrial fibrillation

Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism

Letter by Guo et al Regarding Article, "Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care: The mWellcare Cluster-Randomized Controlled Trial"

Letter by Guo et al Regarding Article, "SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation"

Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: we could do more

Mobile Health (mHealth) technology for improved screening, patient involvement and optimizing integrated care in atrial fibrillation: The mAFA (mAF-App) II randomized trial

Mobile Health Technology for Atrial Fibrillation Management Integrating Decision Support, Education, and Patient Involvement: mAF App Trial

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised Trial

Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation

Mobile health technology facilitates population screening and integrated care management in patients with atrial fibrillation

Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort

Multiple risk factors and ischaemic stroke in the elderly Asian population with and without atrial fibrillation. An analysis of 425,600 Chinese individuals without prior stroke

Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study

Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients

Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

Plasma CX3CL1 levels and long term outcomes of patients with atrial fibrillation: the West Birmingham Atrial Fibrillation Project

Population-Based Screening or Targeted Screening Based on Initial Clinical Risk Assessment for Atrial Fibrillation: A Report from the Huawei Heart Study

Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation

Regular bleeding risk assessment associated with reduction in bleeding outcomes: The mAFA II randomised trial

Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation ⬇️

Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening

Reply: To PMID 22858389.

Risk factors for new-onset atrial fibrillation: A focus on Asian populations

Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation.

Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations

Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: Would the novel oral anticoagulants have an impact? ⬇️

Structured Rehabilitation for Patients with Atrial Fibrillation Based on an Integrated Care Approach: Protocol for a Prospective, Observational Cohort Study

The Challenge of Antiplatelet Therapy in Patients with Atrial Fibrillation and Heart Failure ⬇️

The National Institute for Health Research (NIHR) Global Health Research Group on Atrial Fibrillation management

The potential for photoplethysmographic (PPG)-based smart devices in atrial fibrillation detection

The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia ⬇️

Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation

Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation